+18,881.2%
DINO vs GSK
+1,742.6%
+17,138.6%
-86.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | +0.5% | -0.5% | -0.1% |
| 7D | +5.7% | +1.1% | +4.5% | +5.4% |
| 30D | -19.6% | +6.3% | -25.9% | -20.7% |
| 3M | +11.8% | +1.8% | +10.0% | +11.0% |
| 6M | +49.0% | +1.7% | +47.3% | +47.4% |
| YTD | +128.1% | +6.5% | +121.6% | +121.7% |
| 1Y | +96.3% | +9.5% | +86.8% | +89.5% |
| 3Y | +113.8% | +65.3% | +48.5% | +84.2% |
| 5Y | +252.7% | +43.7% | +208.9% | +211.4% |
| 10Y | +451.4% | +104.1% | +347.3% | +349.2% |
| All | +18,881.2% | +1,742.6% | +17,138.6% | +12,349.8% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling